Polynerve

Developer of medical devices intended for the peripheral nerve injury repair procedure and regeneration.

Other Devices and Supplies
Active
Manchester, United Kingdom Founded 2022
Website ↗
Last updated 2026-08-21
Total raised
$4.3M
Stage
—
Founded
2022
Headcount
—
HQ
Manchester, United Kingdom
Sector
Other Devices and Supplies

About

Polynerve is a medical device company focused on developing solutions for peripheral nerve injury repair and regeneration. The company offers a bioresorbable polymer nerve conduit designed to support directional nerve regeneration, aiming to eliminate the need for autologous nerve grafts and reduce associated risks and complications. Their technology features a micro-grooved internal lumen to enhance Schwann cell infiltration and guide nerve growth. Polynerve has completed Phase I clinical trials.

Funding history · 2 rounds · $4.3M total

2022-10
A Round Undisclosed
2022-07
Seed $4.3M

Q&A

What is Polynerve's primary business focus?
Polynerve is a medical device company that develops solutions for peripheral nerve injury repair and regeneration, specifically a bioresorbable polymer nerve conduit.
When was Polynerve founded?
Polynerve was founded in 2022.
What is the total funding Polynerve has raised to date?
Polynerve has raised a total of $4,290,000 across its funding rounds.
What is the latest known funding round for Polynerve?
Polynerve completed an A Round in October 2022.
What is the core technology offered by Polynerve?
Polynerve's core technology is a bioresorbable polymer nerve conduit designed to support directional nerve regeneration.
What is the purpose of Polynerve's nerve conduit technology?
The nerve conduit aims to eliminate the need for autologous nerve grafts and reduce associated risks and complications in peripheral nerve injury repair.
Has Polynerve conducted clinical trials for its technology?
Yes, Polynerve has completed Phase I clinical trials for its medical device.
Who is the CEO of Polynerve?
Tomer Alon is the CEO of Polynerve.

Team · 5

Tomer Alon
CEO
Prof. Giorgio Terenghi
executives
Prof. Julie Gough
executives
Dr. Adam Reid
Chief Investigator
Mr. Ralph Murphy
executives

Sectors & technology

Primary sector
Other Devices and Supplies
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)